RecruitingNCT04972136
This study is comparing Active Bilateral Theta Burst Stimulation with Sham bilateral theta burst stimulation for people with Autism Spectrum Disorder or depression. Participants receive Active Bilateral Theta Burst Stimulation or Sham bilateral theta burst stimulation and complete study visits and assessments.
DepressionOtherFrom 16 Years to 35 Years
- Countries
- Canada
- Sponsor
- Centre for Addiction and Mental Health
- Condition
- Depression
RecruitingNCT07140575
This study is looking at whether repetitive transcranial magnetic stimulation (rTMS) can help people with Major moderate depression or Feasibility Studies. Participants receive a study treatment and complete follow-up visits and assessments.
DepressionDeviceFrom 14 Years to 19 Years
- Countries
- Canada
- Sponsor
- Sunnybrook Health Sciences Centre
- Condition
- Depression
RecruitingNCT06929533
This study is looking at whether questionnaires and follow-up can help people with Mental Disorder, Pharmacogenetics, Adverse Drug Reaction, or Effectiveness. Participants receive a study treatment and complete follow-up visits and assessments.
Mental healthOtherOver 18 Years
- Countries
- Canada
- Sponsor
- University of Manitoba
- Condition
- Mental health
RecruitingNCT04797364
This study is looking at whether a digital support tool can help people with Mental Health Impairment. Participants receive a study treatment and complete follow-up visits and assessments.
Mental healthOtherFrom 6 Years to 24 Years
- Countries
- Canada
- Sponsor
- University of Calgary
- Condition
- Mental health
RecruitingNCT06032377
This study is looking at whether cognitive behavioural therapy can help people with Insomnia. Participants take part in the program and complete follow-up questionnaires or assessments.
Mental healthOtherFrom 60 Years to 99 Years
- Countries
- Canada
- Sponsor
- Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal
- Condition
- Mental health
RecruitingNCT07413705
This study is looking at whether a digital support tool can help people with Depressive Symptoms, Urinary Incontinence, or Sexual Dysfunction. Participants take part in the program and complete follow-up questionnaires or assessments.
DepressionOtherOver 40 Years
- Countries
- Canada, United States
- Sponsor
- BTL Industries Ltd.
- Condition
- Depression
RecruitingNCT06299319
This study is looking at evaluate the safety, feasibility, and clinical effects of psilocybin administration in those with OCD for people with Obsessive-Compulsive Disorder. Participants receive a study treatment and complete follow-up visits and assessments.
Mental healthOtherFrom 18 Years to 65 Years
- Countries
- Canada
- Sponsor
- Centre for Addiction and Mental Health
- Condition
- Mental health
RecruitingNCT07469527
This study is comparing Placebo with placebo for people with Anxiety, Physiological Stress, or Stress. Participants receive Placebo or placebo and complete study visits and assessments.
AnxietyOtherFrom 21 Years to 55 Years
- Countries
- Canada
- Sponsor
- Botanic Tonics, LLC
- Condition
- Anxiety
RecruitingNCT03954483
This study is comparing Buspirone 10 Mg Oral Tablet with placebo for people with Anxiety. Participants receive Buspirone 10 Mg Oral Tablet or placebo and complete study visits and assessments.
AnxietyOtherFrom 18 Years to 40 Years
- Countries
- Canada
- Sponsor
- University of Manitoba
- Condition
- Anxiety
RecruitingNCT07424404
This study is looking at care and outcomes for people with Schizophrenia or Autism-Related Irritability. Taking part may give some people access to KarXT, but direct benefit is not guaranteed.
SchizophreniaOtherFrom 5 Years to 17 Years
- Countries
- Canada, France, Germany, Hungary, Japan, Poland, Romania, Spain, United States
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Condition
- Schizophrenia
RecruitingNCT05142735
This study is comparing N-Acetylcysteine with placebo for people with Prodromal Schizophrenia. Participants receive N-Acetylcysteine or placebo and complete study visits and assessments.
SchizophreniaOtherFrom 16 Years to 35 Years
- Countries
- Canada
- Sponsor
- Centre for Addiction and Mental Health
- Condition
- Schizophrenia
RecruitingNCT06887192
This study is looking at care and outcomes for people with Psychosis Associated With Alzheimer's Disease. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOtherFrom 55 Years to 90 Years
- Countries
- Canada, United States
- Sponsor
- MapLight Therapeutics
- Condition
- Schizophrenia
RecruitingNCT07428460
This study is looking at whether a digital support tool can help people with Schizophrenia and Predominant Negative Symptoms. Participants take part in the program and complete follow-up questionnaires or assessments.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Canada
- Sponsor
- Douglas Mental Health University Institute
- Condition
- Schizophrenia
RecruitingNCT06410508
This study is looking at whether a mental health workshop can help people with psychosis, Psychiatric Hospitalization, or Engagement. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.
SchizophreniaOtherFrom 19 Years to 35 Years
- Countries
- Canada
- Sponsor
- Nova Scotia Health Authority
- Condition
- Schizophrenia
RecruitingNCT06672588
This study is looking at whether Magnetic Seizure Therapy (MST) can help people with Treatment Resistant Schizophrenia, Schizophrenia, or schizoaffective disorder. Participants take part in Magnetic Seizure Therapy (MST) and complete follow-up assessments.
SchizophreniaOtherOver 18 Years
- Countries
- Canada
- Sponsor
- Centre for Addiction and Mental Health
- Condition
- Schizophrenia
RecruitingNCT07383324
This study is looking at care and outcomes for people with Heat Stress, Physiological Stress, or Cognitive Change. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.
SchizophreniaOtherFrom 18 Years to 85 Years
- Countries
- Canada
- Sponsor
- University of Ottawa
- Condition
- Schizophrenia
RecruitingNCT05500001
This observational study is following people with psychosis, Family Members, Anosognosia, or Paranoia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
SchizophreniaOtherFrom 17 Years to 27 Years
- Countries
- Canada
- Sponsor
- University of Alberta
- Condition
- Schizophrenia
RecruitingNCT05435300
This study is looking at examine changes in synaptic density with transcranial direct current stimulation (tDCS) in the brains of patients with schizophrenia for people with Schizophrenia or Schizoaffective. Participants are followed over time so researchers can learn from clinical and follow-up information.
SchizophreniaOtherOver 18 Years
- Countries
- Canada
- Sponsor
- Centre for Addiction and Mental Health
- Condition
- Schizophrenia
RecruitingNCT05731414
This study is looking at whether cognitive behavioural therapy can help people with Schizophrenia or Psychosis. Participants take part in cognitive behavioural therapy and complete follow-up assessments.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Canada
- Sponsor
- University of Toronto
- Condition
- Schizophrenia
RecruitingNCT05748990
This study is looking at whether a digital support tool can help people with Schizophrenia or Healthy. Participants take part in a digital support tool and complete follow-up assessments.
SchizophreniaOtherFrom 17 Years to 45 Years
- Countries
- Canada
- Sponsor
- Centre for Addiction and Mental Health
- Condition
- Schizophrenia
RecruitingNCT07056894
This study is looking at whether treatment with ABCR helps patients with EPP reduce their alcohol and/or cannabis use for people with Psychosis, Alcohol Use Disorder, or Cannabis Use Disorder. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherFrom 16 Years to 30 Years
- Countries
- Canada
- Sponsor
- Nova Scotia Health Authority
- Condition
- Schizophrenia
RecruitingNCT07001878
This observational study is following people with Psychosis or Cannabis Use to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
SchizophreniaOtherFrom 18 Years to 25 Years
- Countries
- Canada
- Sponsor
- Nova Scotia Health Authority
- Condition
- Schizophrenia
RecruitingNCT06126224
This study is looking at care and outcomes for people with Psychosis Associated With Alzheimer's Disease. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOtherFrom 55 Years to 90 Years
- Countries
- Belgium, Canada, Chile, China, Greece, Hungary, Mexico, Peru, Poland, South Korea, Switzerland, Turkey, United Kingdom, United States
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Condition
- Schizophrenia
RecruitingNCT05980949
This study is looking at care and outcomes for people with Psychosis Associated With Alzheimer's Disease. Taking part may give some people access to KarXT, but direct benefit is not guaranteed.
SchizophreniaOtherFrom 55 Years to 90 Years
- Countries
- Argentina, Belgium, Brazil, Bulgaria, Canada, Chile, China, Croatia, Czech Republic, France, Germany, Greece, Hungary, India, Israel, Italy, Japan, Mexico, Peru, Poland, Portugal, United States, Romania, Serbia, Slovakia, South Korea, Spain, Turkey, Ukraine, United Kingdom
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Condition
- Schizophrenia
RecruitingNCT06373484
This study is looking at whether cognitive behavioural therapy can help people with Disruptive Behavior Disorder, Emotional Disorder, Behavioural Disorder, or Attention Deficit Hyperactivity Disorder. Participants take part in cognitive behavioural therapy and complete follow-up assessments.
ADHDOtherFrom 6 Years to 12 Years
- Countries
- Canada
- Sponsor
- Centre for Addiction and Mental Health
- Condition
- ADHD